We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Customvis | CUS | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.93 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.93 | 0.93 |
| Top Posts |
|---|
Posted at 27/1/2010 09:04 by jaylett Dead on here.The AGM is being held at Moorfields, mid-Feb. Surely no coincidence with the ongoing trial? Per my earlier chat with PVS, progress has been slow. Hopefully a nice trading update and positive trial results around that time. Something needs to happen here to keep investors interested. Jay |
Posted at 16/11/2009 09:10 by jaylett IndunaI have an investment management background and I'm very comfortable with my level of exposure to CUS. The stock currently makes up about 5% of my total portfolio size, which is diversified between small and large caps across a number of sectors I like at present. I have considered adding a couple % more in CUS, pending the upcoming set of results. As you say, concentrating your portfolio in a couple of these volatile small-cap names is a very, very dangerous thing to do. If the last 18 months haven't taught private investors the lesson of diversification then nothing will. Thanks for your concern around my investment strategy, but I'm happy with my current 'predicament'. Jay |
Posted at 13/11/2009 11:11 by tak082 i have lost faith in small cap as they donot intend to inform each and every move they will only portray what they want to customise has no great investors or buyers for the machines. cant see their results out very soon could be a long wait before the dawn i was in at 1.3 and still down by a grand in red cant see mm devolops spreads and keep it down. dyor |
Posted at 25/2/2009 09:34 by tara7 Not a pump and dump, i posted my views, you posted yours, i was right , you were wrong. Who has coned who, any investor who made up their own mind and bought after me a month ago will have done well, very well. Others who took your view have missed out. I state that all the above is in my view, at the end of the day it is up to each one of us as to when to buy or sell. The BB is for all, i never try to stop you posting opp views here do i.? |
Posted at 25/2/2009 09:21 by dell314 tara7 - You've just been posting bull non-stop in your attempt to pump'n'dump this. With some help from a holding RNS, you succeeded, this time. Well done!If you really believed that Novamed might takeover CUS, as you posted, you'd still be holding wouldn't you? Would you con other investors face to face if you met them, or does it feel more sanitised when you do it on a bulletin board... Rgds dell All IMHO, DYOR etc. |
Posted at 02/2/2009 14:30 by tara7 Meeting started 3/4 hours late, to fill in time we were given the 2009 presention to investors. FACT. |
Posted at 25/2/2008 13:14 by c2b £2.23 million unlikely to last long, maybe not even a year, given the sheer cost of attracting sales,especially given the accelerated burn through recruiting further salesmen, increasing marketing effort, increased working capital, preliminary work for FDA trials etc. Remember the board pays itself circa £300,000 per annum, including £152,834 for Mukesh Jain - which puts his investment of £328,250 into the placing in context.Given a ticket price of around £100k per laser, sales of 96 lasers a year would probably see this company making good profits, but I doubt we will see that happening before another funding round. The main risk therefore is that this funding is not big enough, and that many investors will lose out in a trade sale or another highly dilutive fund raising in a year's time. I would suggest that shareholders with a vote present themselves at 7 Devonshire Square at 10am on 17th March, and point out that although the company may have a fine product, the way the company is being run and financed does not make sense to the outside shareholders that invest in it. |
Posted at 04/12/2007 09:42 by schull69 I am a potential small investor in CUS after reading about it in the current'Aim and Plus Newsletter'.I like the company website and the recent Australian awards,but I have a concern and that is the comment by C2B on 2nd Jan regarding the reduction of share option scheme exercise price from 60p to 5p.for two directors.I don't think this smells right and will appreciate comments from people on this bb. |
Posted at 27/7/2007 21:38 by slapdash ur this company has been.. will be and continues to be a con....has achieved little to date apart from deceiving investors multiple times.. floatation price I think 90p a few years ago.. now 4p..... says it all... slap |
Posted at 02/1/2007 22:34 by c2b John McEvoy left the company in February of course, there doesn't now appear to be a Finance Director, seems odd that there's no comment on who now fulfils this function. Good that the compamy got the A$2.3m grant over 2 1/4 years, good that the company managed the placement, but the directors and others are still taking too much of investors money out of the business. The proposed reduction in the company share option scheme exercise price from 60p to 5p seems entirely wrong and the granting of 3 million new options to Paul Van Saarloos at 10p and 1 million options new options to Mukesh Jain at 5p entirely inappropriate. This seems too much of a reward after the poor husbandry of the inital investors resources. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
